This research study aims to evaluate multiple investigational treatments for either newly diagnosed or recurrent brain tumors to determine if any of these study treatment(s) improve overall survival as compared to standard treatments. The investigational drugs that will be used in this research study are temozolomide for newly diagnosed glioblastoma and Lomustine for recurrent glioblastomas.

You may be eligible for this study if you meet the following criteria:

• Conditions: Glioblastoma
• Age: Between 18 Years - 99 Years
• Gender: All